Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study

BACKGROUND: Cancer patients may receive a high number of medications with the potential to prolong QT interval and subsequent TdP (torsades de pointes). This study aimed to identify the prevalence of QT prolonging drugs, their TdP risk, QT prolonging drug-drug interactions (QT-DDIs), levels, predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Qasim, Ismail, Mohammad, Khan, Sehrash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710059/
https://www.ncbi.nlm.nih.gov/pubmed/29191244
http://dx.doi.org/10.1186/s40360-017-0181-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710059/
https://www.ncbi.nlm.nih.gov/pubmed/29191244
http://dx.doi.org/10.1186/s40360-017-0181-2

Ejemplares similares